TGF-β-induced activation of mammalian target of rapamycin (mTOR) activity has also been implicated in multiple fibrotic conditions, including idiopathic pulmonary fibrosis,12 chronic pancreatitis, and cancer-associated fibrosis.13 This evidence concerns the gene MTOR and cancer.